BackXOMA Royalty Overview

XOMA Royalty Current Cash

Track XOMA Royalty's current cash ($94M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$94.46M
↑ 4.65% YoYΔ $4.20M vs prior year quarter

Peer trimmed avg / median

Loading

XOMA Royalty Current Cash History

Loading

XOMA Royalty vs. peers: Current Cash Comparison

Loading

XOMA Royalty Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

XOMA Royalty (XOMA) FAQ

XOMA Royalty (XOMA) currently reports a current cash of $94M as of March 2026. That compares with $90M in the prior-year period — up 4.6% year over year. Use the charts on this page to explore XOMA Royalty's current cash history and peer comparisons.

XOMA Royalty's current cash increased from $90M to $94M — a 4.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

XOMA Royalty reported $94M in current cash as of March 2026. That compares with $90M in the prior-year period — up 4.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $94M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for XOMA Royalty, and consider following XOMA for alerts when major investors trade the stock.

XOMA Royalty is classified in the Healthcare sector. On current cash, it currently shows $94M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XOMA with unrelated industries.